Dbv technologies to participate in upcoming acaai 2024 congress

ChÂtillon, france, october 18, 2024 dbv technologies to participate in upcoming acaai 2024 congress dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company, today announced upcoming participation at the american college of allergy, asthma & immunology (acaai) annual scientific meeting, october 24 – 28th, 2024 in boston, massachusetts. this year's meeting will feature a “product theater” on what defines an optimal peanut allergy treatment?
DBVT Ratings Summary
DBVT Quant Ranking